Abstract

Objectives: To evaluate whether incorporating the radiomics, genomics, and clinical features allows prediction of metastasis in colorectal cancer (CRC) and to develop a preoperative nomogram for predicting metastasis.Methods: We retrospectively analyzed radiomics features of computed tomography (CT) images in 134 patients (62 in the primary cohort, 28 in the validation cohort, and 44 in the independent-test cohort) clinicopathologically diagnosed with CRC at Dazhou Central Hospital from February 2018 to October 2019. Tumor tissues were collected from all patients for RNA sequencing, and clinical data were obtained from medical records. A total of 854 radiomics features were extracted from enhanced venous-phase CT of CRC. Least absolute shrinkage and selection operator regression analysis was utilized for data dimension reduction, feature screen, and radiomics signature development. Multivariable logistic regression analysis was performed to build a multiscale predicting model incorporating the radiomics, genomics, and clinical features. The receiver operating characteristic curve, calibration curve, and decision curve were conducted to evaluate the performance of the nomogram.Results: The radiomics signature based on 16 selected radiomics features showed good performance in metastasis assessment in both primary [area under the curve (AUC) = 0.945, 95% confidence interval (CI) 0.892–0.998] and validation cohorts (AUC = 0.754, 95% CI 0.570–0.938). The multiscale nomogram model contained radiomics features signatures, four-gene expression related to cell cycle pathway, and CA 19-9 level. The multiscale model showed good discrimination performance in the primary cohort (AUC = 0.981, 95% CI 0.953–1.000), the validation cohort (AUC = 0.822, 95% CI 0.635–1.000), and the independent-test cohort (AUC = 0.752, 95% CI 0.608–0.896) and good calibration. Decision curve analysis confirmed the clinical application value of the multiscale model.Conclusion: This study presented a multiscale model that incorporated the radiological eigenvalues, genomics features, and CA 19-9, which could be conveniently utilized to facilitate the individualized preoperatively assessing metastasis in CRC patients.

Highlights

  • Colorectal cancer (CRC) is a common malignant tumor, for which the incidence of men is usually higher than women

  • CA 19-9 showed a significant difference between metastasis and non-metastasis groups in the primary cohort (P < 0.05), which was confirmed in the validation cohort (P < 0.05) (Table 1)

  • Using the least absolute shrinkage and selection operator (LASSO) regression model, 854 texture features were reduced to 16 potential predictors

Read more

Summary

Introduction

Colorectal cancer (CRC) is a common malignant tumor, for which the incidence of men is usually higher than women. In 2012, more than 690,000 people died of CRC worldwide [1]. The main treatment of CRC is surgical resection, supplemented by chemotherapy or radiotherapy. More than 20% of patients are still life-threatening because of disease metastasis [2]. Accurate prediction of tumor metastasis is of great significance for the individualized treatment and prognosis of patients with CRC [3]. In CRC patients, the venous phase of enhanced CT scan shows a stronger resolution and good response to the size and scope of tumors [8]. We need to find more specific method to distinguish CRC metastasis

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call